Inventor · disambiguated record
Nathan Boersen
Also filed as: BOERSEN NATHAN · BOERSEN NATHAN ANDREW
8 granted patents·44 citations·filing 2012–2018
84Inventor score
Top patents by PatentIndex Score
8 records- 0192US9359364B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2014·Granted Jun 7, 2016·10 cites·28 claims
- 0291US9796685B2Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methylcyclohexylamino)-pyrimidine-5-carboxamideSIGNAL PHARM LLC·Filed 2015·Granted Oct 24, 2017·14 cites·7 claims
- 0388US9403829B2Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their useSIGNAL PHARM LLC·Filed 2012·Granted Aug 2, 2016·13 cites·29 claims
- 0484US10131639B2Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methylcyclohexylamino)-pyrimidine-5-carboxamideSIGNAL PHARM LLC·Filed 2017·Granted Nov 20, 2018·4 cites·18 claims
- 0574US10590089B2Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamideSIGNAL PHARM LLC·Filed 2018·Granted Mar 17, 2020·1 cites·48 claims
- 0665US10052322B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2017·Granted Aug 21, 2018·0 cites·18 claims
- 0764US9884042B2Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amideBOERSEN NATHAN·Filed 2012·Granted Feb 6, 2018·2 cites·12 claims
- 0850US9981971B2Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one as TOR kinase inhibitorsSIGNAL PHARM LLC·Filed 2016·Granted May 29, 2018·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →